Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Williams

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 28, 2021
Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: a Novel Cause of Severe Growth Hormone InsensitivityEmily Cottrell, Avinaash Maharaj, Jack Williams, et al.
Health Technology Assessment (Winchester, England)|April 30, 2021
Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCTIan Roberts, Haleema Shakur-Still, Amy Aeron-Thomas, et al.
Journal of Medical Imaging and Radiation Sciences|October 6, 2022
Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experienceJack Williams, Kevin Mc Millan, Damien Bolton, et al.
Infection and Immunity|April 20, 2006
Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite proteinMichael Walther, Fiona M Thompson, Susanna Dunachie, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Nature Cardiovascular Research|September 13, 2024
Tissue-resident memory T cells in epicardial adipose tissue comprise transcriptionally distinct subsets that are modulated in atrial fibrillationVishal Vyas, Balraj Sandhar, Jack M Keane, et al.
The Journal of Infectious Diseases|July 3, 2009
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protectionKent E Kester, James F Cummings, Opokua Ofori-Anyinam, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2009
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by designKelley M VanBuskirk, Matthew T O'Neill, Patricia De La Vega, et al.
Vaccine|December 18, 2004
Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720Michael Walther, Susanna Dunachie, Sheila Keating, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|August 28, 2021
Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: a Novel Cause of Severe Growth Hormone InsensitivityEmily Cottrell, Avinaash Maharaj, Jack Williams, et al.
Health Technology Assessment (Winchester, England)|April 30, 2021
Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCTIan Roberts, Haleema Shakur-Still, Amy Aeron-Thomas, et al.
Journal of Medical Imaging and Radiation Sciences|October 6, 2022
Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experienceJack Williams, Kevin Mc Millan, Damien Bolton, et al.
Infection and Immunity|April 20, 2006
Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite proteinMichael Walther, Fiona M Thompson, Susanna Dunachie, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Nature Cardiovascular Research|September 13, 2024
Tissue-resident memory T cells in epicardial adipose tissue comprise transcriptionally distinct subsets that are modulated in atrial fibrillationVishal Vyas, Balraj Sandhar, Jack M Keane, et al.
The Journal of Infectious Diseases|July 3, 2009
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protectionKent E Kester, James F Cummings, Opokua Ofori-Anyinam, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2009
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by designKelley M VanBuskirk, Matthew T O'Neill, Patricia De La Vega, et al.
Vaccine|December 18, 2004
Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720Michael Walther, Susanna Dunachie, Sheila Keating, et al.
Pageof 6